87 results on '"Swain, Mark G."'
Search Results
2. WED-274 Impact of sex, body mass index, elevated liver enzymes, and diabetes mellitus on risk-stratification of a large cohort of patients with MASLD
3. TOP-169 Sex, ethnicity and clinical outcomes in autoimmune hepatitis: results from a large multicenter longitudinal cohort
4. LBP-006 Efficacy of elafibranor in primary biliary cholangitis: results from the variable double-blind period of ELATIVE®, a randomised, placebo-controlled phase III trial
5. OS-018 Liver stiffness measurement by vibration-controlled transient elastography predicts adverse clinical outcomes in autoimmune hepatitis: results from a large multicenter longitudinal study
6. Treatment response and clinical event-free survival in autoimmune hepatitis: A Canadian multicentre cohort study
7. Metabolic dysfunction-associated steatotic liver disease: An opportunity for collaboration between cardiology and hepatology
8. A global research priority agenda to advance public health responses to fatty liver disease
9. Risk-stratification of patients with non-alcoholic fatty liver disease (NAFLD) in primary care: lessons from the Calgary NAFLD pathway
10. Loss of innate and adaptive effector lymphocytes is associated with diminished globe score prognosis in patients with primary biliary cholangitis
11. Cholestatic liver disease enhances sociability and leads to significant adaptative changes in amygdala neural circuits regulating social behavior in mice
12. Detrimental association between COVID-19 pandemic stages and alcoholic hepatitis admissions: a Canadian population-based study
13. Vibration-controlled transient elastography predicts clinical outcomes in patients with autoimmune hepatitis
14. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis
15. Association Between Endoscopist Specialty and Colonoscopy Quality: A Systematic Review and Meta-analysis
16. A phase II, randomized, open-label, 52-week study of seladelpar in patients with primary biliary cholangitis
17. The prevalence of primary biliary cholangitis (PBC) is on the rise: a canadian population-based study
18. Quality of life outcomes in patients with primary biliary cholangitis treated with setanaxib: post-hoc results from a phase 2 randomised, placebo-controlled trial
19. Increased hospital admissions for alcohol-associated hepatitis during the COVID-19 pandemic in Alberta, Canada: a retrospective cohort study
20. Validation of a novel method of identifying patients with Primary Sclerosing Cholangitis (PSC) in a canadian population
21. Tu1261: IMPACT OF THE COVID-19 PANDEMIC ON THE EPIDEMIOLOGY OF ALCOHOL-ASSOCIATED HEPATITIS
22. Tu1251: INCIDENCE AND PREVALENCE OF PRIMARY SCLEROSING CHOLANGITIS: A META-ANALYSIS OF POPULATION-BASED STUDIES
23. Colitis-associated microbiota drives changes in behaviour in male mice in the absence of inflammation
24. Impact of the COVID-19 Pandemic on Hospitalizations for Alcoholic Hepatitis or Cirrhosis in Alberta, Canada
25. The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge?
26. The Worldwide Burden of NAFLD: A Systematic Review and Meta-Analysis of Prevalence and Incidence
27. Behavioural adaptations after antibiotic treatment in male mice are reversed by activation of the aryl hydrocarbon receptor
28. Evaluating the role of transient elastography post chronic hepatitis C treatment to predict hepatocellular carcinoma
29. Brain TNF drives post-inflammation depression-like behavior and persistent pain in experimental arthritis
30. The burden of cirrhosis on the Canadian healthcare system: a comparison between alcoholic and non-alcoholic cirrhosis patients
31. A new score including anthropometric measurement for weight improved prediction of mortality in adolescents on the liver transplantation waiting list: a US nationwide study
32. Role of pre- and post-treatment transient elastography measurements in predicting hepatocellular carcinoma (HCC) among hepatitis C patients treated with direct acting antivirals (DAAs)
33. Performance of non-invasive fibrosis tests among non-alcoholic fatty liver disease (NAFLD) patients with normal alanine aminotransferase (ALT): data from a large North American primary care NAFLD pathway
34. Durability of treatment response after 1 year of therapy with seladelpar in patients with primary biliary cholangitis (PBC): final results of an international phase 2 study
35. 686 EFFECTS ON PRURITUS AND SLEEP DISTURBANCE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS (PBC) AFTER 1 YEAR OF TREATMENT WITH SELADELPAR, A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA AGONIST: RESULTS OF AN OPEN-LABEL PHASE 2 STUDY
36. Mo1931 – Urine Metabolomic Signatures Differentiate Pregnancy from the Non-Pregnant State and Differ in Pregnant Patients with Crohn’s Disease Compared with Ulcerative Colitis
37. Mo1284 – Comparing Outcomes in Upper Gastrointestinal Bleeding for Patients Living Within Vs Outside Large Urban Centres: A Population-Based Cohort Study
38. FRI-309-Hepatitis B virus B and T cell specific responses are reduced in adults with a body mass index > 35 and non-alcoholic fatty liver disease and in a mice model of NAFLD compared to adults with a BMI of > 35 patients and normal animals
39. PS-175-The burden of alcoholic cirrhosis is critically increasing in Canada: A population-based study
40. FRI-055-Failure to normalize ALT and IgG in Autoimmune Hepatitis is associated with more advanced liver disease: Perspectives from a multi-ethnic Canadian AIH registry
41. SAT-325-Implementation of a primary care shear-wave elastography-based pathway to identify non-alcoholic fatty liver disease patients with advanced fibrosis in a large North American urban population
42. GS-02-Efficacy of GKT831 in patients with primary biliary cholangitis and inadequate response to ursodeoxycholic acid: Interim efficacy results of a phase 2 clinical trial
43. FRI-056-Obeticholic acid as adjunctive therapy in Primary Biliary Cholangitis: A review of early real-world experience
44. THU-252-Nursing staff volume is the most significant predictor of improved in-hospital mortality among alcoholic hepatitis patients admitted with ascites or hepatic encephalopathy: US nationwide population-based study
45. Role of Peripheral Inflammation in Hepatic Encephalopathy
46. Long-Term Follow-up and Quantitative Hepatitis B Surface Antigen Monitoring in North American Chronic HBV Carriers
47. Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study
48. Clinical prediction rule to determine the need for repeat ERCP after endoscopic treatment of postsurgical bile leaks
49. Tumor Necrosis Factor Alpha (Tnfα) Cleaving Enzyme (TACE/ADAM17) Expression is Enhanced in Cholestatic Liver Disease and Regulates Cholestasis-Associated Liver Injury and Sickness Behavior Development
50. Depression Is Associated with an Increased Risk of Psoriatic Arthritis among Patients with Psoriasis: A Population-Based Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.